Heidi Turner has been a contributor since 2006. As a freelance writer, she has had her work published in various news outlets and magazines. In her spare time, Heidi entertains her four cats and travels as much as her budget allows. You can visit Heidi at www.heiditurner.ca
Fort Dodge, IA: Karen C. (not her real name) says she did everything that Sprint customer service representatives told her to do. She says she was even told that when she moved, she would not be charged an early termination fee. However, she was charged a fee of $1,000, and she says every time she phones Sprint, she speaks to a new customer service representative, who gives her different answers to her questions.
New York, NY: Despite company promises about prorating cell phone early termination fees, many consumers still report that they are being charged outrageous fees for canceling contracts that they thought had already expired.
Dallas, TX: Consumers are already writing to LawyersandSettlements, concerned about their Kitec XPA pipes. Some report that their pipes have burst, while others are simply concerned that theirs could burst at any time and there is nothing they can do about it.
Rockville, MD: A Food and Drug Administration (FDA) panel will meet in March to discuss the possibility of restricting sales of drugs including Procrit, Epogen and Aranesp. The drugs are all intended to fight anemia that is caused by chemotherapy; however, their safety has been called into question by recent studies.
Flint MI: The complaints are pouring in to LawyersandSettlements from customers who are unhappy about the short lifespan of their defective Toshiba television sets. Specifically, they are upset that the bulbs in the set burn out much more quickly than they were supposed to. Some customers say they even had to pay for replacement bulbs themselves, even though the warranty on their televisions had not expired.
Rockville, MD: The US Food and Drug Administration (FDA) has announced it is now reviewing new data from studies that show potential risks associated with anemia drugs. Those risks include a more rapid progression of tumor growth in patients with breast cancer or advanced cervical cancers.